JPMorgan Chase
JPM
$300.25
-1.52%
JPMorgan Chase & Co. is a leading global financial services firm operating as a diversified bank with a $4.9 trillion balance sheet, serving clients across consumer and community banking, commercial and investment banking, and asset and wealth management. It is the undisputed market leader in investment banking fees and a dominant force in US retail banking with over 5,000 branches, distinguished by its scale, fortress balance sheet, and integrated financial platform. The current investor narrative revolves around the bank's resilience and earnings trajectory amidst a volatile macroeconomic backdrop, with attention focused on its ability to navigate interest rate uncertainty, manage credit costs, and sustain its leadership in investment banking and wealth management as evidenced by recent quarterly results.…
JPM
JPMorgan Chase
$300.25
Related headlines
Investment Opinion: Should I buy JPM Today?
Rating & Thesis: JPMorgan is a Hold. The core thesis is that the stock represents a high-quality, defensive holding within the financial sector, but near-term macro headwinds and decelerating growth limit upside, aligning with the stable but not overly bullish institutional analyst ratings.
Supporting Evidence: The valuation is reasonable, with a forward P/E of 13.29x implying earnings growth and sitting below the stock's own recent historical multiple of 17.25x. Profitability is exceptional, evidenced by a 15.74% ROE and $100.87B in TTM FCF. However, revenue growth has moderated to 3.88% YoY in Q4, and the stock's persistent underperformance versus the market (-9.68% YTD) reflects these growth concerns. The dividend yield of 1.85% provides a modest income cushion.
Risks & Conditions: The two biggest risks are a deeper-than-expected economic slowdown hitting credit quality and a prolonged period of sector underperformance. This Hold rating would upgrade to a Buy if the forward P/E compressed below 12x on sustained earnings growth, or if revenue growth re-accelerated above 5% YoY. It would downgrade to a Sell if credit costs surged, pushing net income below the $13.03B reported in Q4, or if the stock broke below its $248.83 support level. Relative to its own history and justified by its superior metrics, the stock is fairly valued.
Sign up to view all
JPM 12-Month Price Forecast
JPMorgan is a fundamentally strong company trading in a challenging macro environment for its sector. The high confidence in its operational excellence (ROE, FCF) is offset by medium confidence in the near-term path for bank stocks overall, given the negative relative strength and growth deceleration. The stance is neutral, as the stock appears fairly valued with balanced risk/reward. An upgrade to bullish would require a clear inflection in revenue growth or a decisive sector rotation. A downgrade to bearish would be triggered by a breakdown of key technical support at $248.83, signaling a fundamental deterioration in the outlook.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on JPMorgan Chase's 12-month outlook, with a consensus price target around $390.32 and implied upside of +30.0% versus the current price.
Average Target
$390.32
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$240 - $390
Analyst target range
Analyst coverage for this mega-cap bank is extensive, though the provided data shows only 5 analysts with specific estimates, which is a limited sample. The consensus sentiment, inferred from the institutional ratings, leans bullish, with recent actions from firms like Piper Sandler, Wells Fargo, and Barclays maintaining 'Overweight' or 'Outperform' ratings. The average target price is not explicitly provided in the given data, so the implied upside cannot be calculated. The target range for estimated EPS is provided, from a low of $24.29 to a high of $27.68, with an average of $25.78, indicating a relatively tight spread of about 13% between the high and low estimates. This suggests a moderate level of uncertainty or a strong consensus on the earnings outlook. The high EPS target likely assumes a favorable interest rate environment, sustained investment banking activity, and contained credit losses, while the low target may price in an economic slowdown or margin compression. The pattern of recent institutional ratings shows stability, with no downgrades in the listed actions, only reaffirmations of existing positive or neutral ratings, indicating steady analyst conviction.
Bulls vs Bears: JPM Investment Factors
The bull case for JPMorgan is anchored in its unparalleled financial strength, profitability, and a valuation that has de-rated from recent highs, offering a compelling entry point for a quality franchise. The bear case focuses on decelerating growth, macro sensitivity, and persistent sector outflows that could cap upside. Currently, the bull side holds stronger evidence, as the company's fortress fundamentals (massive FCF, high ROE) provide a durable moat against cyclical pressures. The single most important tension in the investment debate is whether JPMorgan's superior execution and scale can drive earnings growth sufficient to overcome the sector's macro headwinds and attract capital back from higher-growth market segments.
Bullish
- Fortress Balance Sheet & Cash Flow: JPMorgan generates an immense $100.87 billion in trailing free cash flow, providing a massive buffer for shareholder returns and strategic flexibility. This underpins a 29.14% dividend payout ratio and supports the bank's 'fortress' reputation with a $4.9 trillion balance sheet.
- Superior Profitability Metrics: The bank maintains best-in-class profitability with a 15.74% Return on Equity and a 20.39% net margin. These metrics, alongside a 59.11% gross margin, demonstrate superior operational efficiency and pricing power compared to peers.
- Valuation De-Rating Creates Opportunity: The trailing P/E of 15.75x has compressed from 17.25x at the end of Q4 2025, and the forward P/E of 13.29x implies expected earnings growth. This de-rating, likely due to macro concerns, offers a relative value entry point for a high-quality franchise.
- Diversified, Market-Leading Segments: Revenue is balanced across major divisions, with Consumer & Community Banking and Commercial & Investment Bank each contributing ~$19.4 billion recently. This diversification, coupled with an 8.4% global investment banking fee market share, reduces single-point failure risk.
Bearish
- Revenue & Earnings Growth Deceleration: Q4 2025 revenue of $69.61B grew only 3.88% YoY and declined sequentially from Q3's $71.90B. Similarly, net income fell from $14.39B in Q3 to $13.03B in Q4, indicating potential cyclical pressure on top and bottom lines.
- Macro Sensitivity & Interest Rate Risk: As a bank with a beta of 1.04, JPM is highly sensitive to economic cycles and interest rate policy. Recent news highlights geopolitical volatility and inflation uncertainty, which can compress net interest margins and increase credit loss provisions.
- Persistent Relative Underperformance: The stock shows negative relative strength versus the SPY across all measured periods (-9.68% YTD, -5.23% over 6 months). This indicates consistent capital outflow from the sector despite the company's strong fundamentals, reflecting broader market skepticism towards banks.
- Elevated Leverage & Sector Headwinds: The debt-to-equity ratio of 2.60, while normal for a bank, exposes the balance sheet to funding cost increases and regulatory scrutiny. Sector-wide concerns about commercial real estate and consumer credit in a potential slowdown pose tangible risks.
JPM Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a robust 26.56% one-year price change. However, the current price of $312.47 sits at approximately 72% of its 52-week range ($248.83 to $337.25), indicating it is trading meaningfully below its recent highs and has retreated from peak momentum. This positioning suggests the stock is consolidating after a strong run, offering a potential entry point but also reflecting investor caution amid broader market volatility. Recent short-term momentum has turned positive, with a 5.79% gain over the past month, which contrasts with a more modest 2.15% gain over three months. This one-month acceleration suggests a potential recovery attempt from the lows seen in March 2026, though it has yet to decisively reverse the longer-term consolidation. The stock's beta of 1.04 indicates its volatility is nearly identical to the broader market (SPY), which is typical for a mega-cap bank, implying its price movements are more driven by fundamental and sector-specific factors than systemic market risk. Key technical support is anchored at the 52-week low of $248.83, while immediate resistance lies at the 52-week high of $337.25. A breakout above $337.25 would signal a resumption of the primary bull trend, whereas a breakdown below the $248.83 support would indicate a more severe deterioration in sentiment, potentially triggered by a recessionary or systemic financial shock.
Beta
1.02
1.02x market volatility
Max Drawdown
-15.5%
Largest decline past year
52-Week Range
$256-$337
Price range past year
Annual Return
+14.2%
Cumulative gain past year
| Period | JPM Return | S&P 500 |
|---|---|---|
| 1m | -4.3% | +8.2% |
| 3m | -0.8% | +9.0% |
| 6m | -1.1% | +10.5% |
| 1y | +14.2% | +26.5% |
| ytd | -7.8% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JPM Fundamental Analysis
Revenue growth remains positive but has shown signs of deceleration. For Q4 2025, revenue was $69.61 billion, representing a 3.88% year-over-year increase. However, this marks a sequential decline from the $71.90 billion reported in Q3 2025, and the quarterly trend through 2025 shows revenue peaked in Q3 before moderating. Segment data from a recent period indicates balanced contributions, with Consumer & Community Banking at $19.40 billion and the Commercial & Investment Bank at $19.38 billion, suggesting diversified drivers but no single hyper-growth engine. The company is highly profitable, with Q4 2025 net income of $13.03 billion and a net margin of 20.39%. Gross margin for the quarter was 59.11%, and the operating margin was 25.95%, reflecting strong operational efficiency. Profitability has been consistent, though net income of $13.03 billion in Q4 was down from $14.39 billion in Q3, indicating some quarterly pressure, potentially from provision builds or normalized trading revenues. The balance sheet and cash flow position are exceptionally strong, underpinning the 'fortress' narrative. The company generated a massive $100.87 billion in trailing twelve-month free cash flow. Its Return on Equity (ROE) is a robust 15.74%, and while the debt-to-equity ratio of 2.60 is elevated due to the nature of banking operations, it is managed within a conservative framework given the firm's asset quality. The substantial FCF provides ample capacity for dividend payments (payout ratio of 29.14%) and share repurchases, reducing dependence on external capital markets.
Quarterly Revenue
$69.6B
2025-12
Revenue YoY Growth
+0.03%
YoY Comparison
Gross Margin
+0.59%
Latest Quarter
Free Cash Flow
$100.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JPM Overvalued?
Given the company's substantial and consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 15.75x, while the forward PE is lower at 13.29x. This gap suggests the market anticipates earnings growth, with forward estimates implying an earnings increase that justifies a lower multiple on future profits. Compared to typical industry averages for diversified banks, JPMorgan's trailing PE of 15.75x likely trades at a premium, justified by its superior scale, profitability (ROE of 15.74%), and market-leading positions across its business segments. This premium reflects the market's assessment of its quality and defensive characteristics. Historically, the stock's own valuation provides context. The current trailing PE of 15.75x is below the 17.25x reported at the end of Q4 2025, as per the historical ratios data. This indicates the stock has de-rated from its recent historical level, trading closer to the middle of its own historical band rather than at optimistic highs. This compression could be due to macroeconomic concerns weighing on bank multiples, potentially presenting a relative value opportunity if the company's fundamentals remain intact.
PE
15.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: JPMorgan's primary financial risk is its sensitivity to interest rate movements and credit cycles, given its $4.9 trillion balance sheet. While profitability is robust (20.39% net margin), the sequential decline in Q4 2025 net income from $14.39B to $13.03B signals potential earnings volatility. Revenue concentration is not a major issue due to segment diversification, but the bank's elevated debt-to-equity ratio of 2.60, standard for the industry, means earnings are leveraged to changes in funding costs and asset quality.
Market & Competitive Risks: The stock trades at a trailing P/E of 15.75x, which is likely a premium to many regional bank peers, justified by its quality. The key market risk is valuation compression if macroeconomic conditions worsen, further extending the stock's negative relative strength trend (e.g., -9.68% YTD vs. SPY). Competitive disruption from fintech is a long-term threat, but JPM's scale and integrated platform provide a strong defense. The beta of 1.04 confirms the stock moves nearly in lockstep with the broad market, making it vulnerable to sector rotations away from financials.
Worst-Case Scenario: A severe economic recession coupled with a systemic financial shock (e.g., a commercial real estate crisis) would trigger a chain of events: a spike in credit loss provisions, a collapse in investment banking activity, and net interest margin compression. This could lead to earnings collapsing towards the low end of analyst estimates ($24.29 EPS) and multiple contraction towards the 52-week low. The realistic downside from the current price of $312.47 is approximately -21% to the 52-week low of $248.83. A drawdown of this magnitude is plausible given the stock's 15.47% maximum drawdown in the recent data period.
FAQ
The key risks are, in order of severity: 1) Macroeconomic & Interest Rate Risk: A recession or adverse rate environment could compress margins and increase credit losses, directly impacting the $4.9 trillion balance sheet. 2) Sector Sentiment Risk: Persistent capital outflow from financials, evidenced by negative relative strength versus the SPY for over a year, can cap upside regardless of company performance. 3) Execution & Growth Risk: Revenue growth has decelerated to 3.88% YoY; a further slowdown would challenge earnings targets. 4) Leverage Risk: The debt-to-equity ratio of 2.60, while standard, exposes the firm to funding cost volatility.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $300 and $337, as it executes steadily in a muddle-through economy, hitting consensus EPS of ~$25.78. The Bull Case (25% probability) targets $337 to $365, requiring a soft landing, Fed rate cuts, and a sector re-rating. The Bear Case (15% probability) warns of a drop to $248-$290 in a recessionary scenario with rising credit costs. The most likely outcome is the Base Case, which assumes JPM's fundamentals hold but macro headwinds prevent a significant breakout.
JPM stock is fairly valued relative to its own history and quality. The trailing P/E of 15.75x represents a de-rating from its recent level of 17.25x, likely reflecting macro concerns. The forward P/E of 13.29x implies the market expects earnings growth. Compared to the broader banking sector, JPM likely trades at a premium, which is justified by its superior scale, profitability (20.39% net margin), and market leadership. The valuation implies the market is paying a fair price for a best-in-class franchise, not anticipating significant multiple expansion without a change in the sector's growth outlook.
JPM is a good buy for investors seeking a defensive, high-quality holding in the financial sector, but not for those chasing high growth. The stock offers a reasonable valuation (13.29x forward P/E), a solid 1.85% dividend, and exceptional profitability (15.74% ROE). However, with revenue growth decelerating to 3.88% and the stock showing persistent underperformance versus the market, near-term upside is likely capped. It is a good buy for patient, long-term investors who can tolerate sector volatility, but less attractive for short-term traders.
JPM is unequivocally suitable for long-term investment, with a suggested minimum holding period of 3-5 years. Its business model benefits from scale and compounding over time, and its 1.85% dividend contributes to total return. The stock's beta of 1.04 indicates market-like volatility, making it less ideal for short-term trading where sector rotations and macro news can cause sharp swings. Long-term investors can look through cyclical downturns to capture the value created by its fortress balance sheet, consistent profitability, and shareholder return program.